Local Institution - 706

Maebashi 371-8511

0 studies enrolling now · 1 studies all time

What they study most

Anemia, Myelofibrosis, Myeloproliferative Disorders, Post-Polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions — Running, not enrolling